3SBio (SSRX) Files for Chinese State FDA Approval of 36,000 IU Dosage of EPIAO
Tweet Send to a Friend
3SBio Inc. (Nasdaq: SSRX) today announced that it has filed with the Chinese State Food and Drug Administration for approval ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
